Methods, systems, and apparatus are described providing networking engines. Specifically, the present specification relates to a method for implementing software containers implementing network engines that may be configured to act in a zero-knowledge environment. In such implementations, all information pertaining to the network engine associated with a user that is stored in the container is solely that of a user unless explicitly shared by the user. In some implementations, the containers may be configured to participate in a publish-and-subscribe network in order to share information. In addition, the containers may be provisioned with controls so that global operators may comply with local privacy rules.

The present invention relates to medical device programming assemblies, systems and methods for programming a medical treatment parameter on a medical device, via a programming key. The programming key may be adapted to mate with the medical device which comprises a programmable, non-transitory, computer readable storage device. The storage device comprises a data connector which is configured to mate with a corresponding data connector on the medical device. The storage device may be affixed to a fastener coupling configured to mate with a corresponding coupling on the medical device when the data connector is brought into proximity with the corresponding data connector on the medical device. The programming key is configured to occupy a space formed within the medical device when the data connector and fastener coupling are mated with the corresponding data connector and fastener coupling of the medical device.

A method for conducting a bioprocess with a digital control unit of a bioprocess arrangement, wherein the digital control unit comprises a local data storage and a local processor unit, wherein bioprocess data are generated by the digital control unit. It is proposed, that in a data safety routine, a documentation routine and a signing routine are executed, that in the documentation routine, documentation data are generated from the bioprocess data and that in the signing routine, a cryptographic private key is extracted from private key data and the documentation data are digitally signed with the cryptographic private key by generating a digital signature and that the documentation routine is executed continuously during the bioprocess and that the signing routine is executed discontinuously during the bioprocess in several signing cycles according to a signing strategy, which defines trigger events for initiating the signing routine.

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.

A blockchain network control system and method is disclosed. The system includes a processor coupled to a storage comprising a plurality of network entity definitions each defining a different network entity that make up a target network architecture for a permissioned blockchain network. The system also includes a control object communicatively coupled to an ordering service and a plurality of organizations. The plurality of organizations was established by the blockchain network control system by instantiating the organizational membership service provider, registering and enrolling each peer node within each organization, storing the cryptographic identity generated for the peer node, and then instantiating the plurality of peer nodes. The ordering service was established by the blockchain network control system by instantiating the ordering membership service provider, registering and enrolling each orderer node belonging to the ordering service, storing the cryptographic identity generated for the orderer node, and then instantiating the orderer nodes.

Smart flow contracts using distributed ledger technologies in a cloud based computing environment are described herein. For example, a system may include a processor and a memory therein executing within a host organization and having therein: means for operating a blockchain interface to a blockchain on behalf of tenants of the host organization. The tenants may be participating nodes with the blockchain. A login request may be received from a user device. The user device may be authenticated with the host organization. Input from the user device indicating a plurality of smart contract blocks may be received. The smart contract blocks may be translated into a native programming language to form a smart contract to execute via the blockchain. The smart contract may be transacted onto the blockchain.

A medical device of a medical system is configured for communicating with an external programmer over a wireless communications link. The medical device comprises a wireless communications module configured for receiving a first unencrypted version of a random number and a first encrypted version of the random number from the external programmer over the wireless communications link. The medical device further comprises control circuitry configured for performing an authentication procedure on the external programmer based on the first unencrypted version of the random number and the first encrypted version of the random number, and preventing the external programmer from commanding the medical device to perform an action unless the authentication procedure is successful.

According to some embodiments of the present disclosure, a device is disclosed. In embodiments, the device stores a computer program comprised of a set of encoded executable instructions; a genomic differentiation object and genomic regulation instructions (GRI) that were used to encode the set of encoded executable instructions. The device further includes a processing system comprising a VDAX and a set of processing cores. The VDAX is configured to: receive encoded instructions to be executed from the set of encoded executable instructions and decode the encoded instructions into decoded executable instruction based on a modified genomic differentiation object and sequences extracted from metadata associated with the encoded instructions. In these embodiments, the modified genomic differentiation object is modified from the genomic differentiation object using the GRI. The set of processing cores are configured to receive the decoded executable instructions from the VDAX and to execute the decoded executable instructions.

A data structure of a ledger file includes an object identifier that identifies the ledger file for an asset related to a physical entity; a digital model of the asset; attributes, each attribute corresponding to a detail associated with the asset related to the physical entity and having properties providing a record of information about the asset or the detail associated therewith; and an updates index for storing security tags, each security tag having information including a block hash and a timestamp. A data storage and retrieval system for one or more computers includes a ledger file generator that generates a data structure of a ledger file in the one or more computers and an updater that assigns a corresponding security tag to an updates index for indexing each newly added record of information of an attribute to the ledger file.

A method for maintaining a material data blockchain (MDC) is disclosed. The method includes receiving a material data block (MDB), wherein the MDB includes a metadata portion and a payload portion. The method further includes extracting a first sequence from the metadata portion and generating a genomic engagement factor (GEF) based on the sequence, a genomic differentiation object assigned to the creator VDAX, and genomic regulation instructions (GRI) that are maintained by the creator VDAX. The method further includes generating a creator value corresponding to the MDB based on the first GEF and the MDB and digitally signing the MDB with the creator value. The method includes providing the unnotarized MDB to one or more notary cohorts; and receiving a respective notary value from each of the notary cohorts, wherein each notary value is generated using respective GRI and genomic differentiation object maintained by a respective notary.